# FDA Inspection 826074 - Michael L. Levin, M.D. - April 03, 2013

Source: https://www.keypedia.com/records/fda_inspections/michael-l-levin-md/e1cfd7cd-263e-4d2b-a8ce-7618caf7308d
Source feed: FDA_Inspections

> FDA Inspection 826074 for Michael L. Levin, M.D. on April 03, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 826074
- Company Name: Michael L. Levin, M.D.
- Inspection Date: 2013-04-03
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1133566 - 2020-11-25](https://www.keypedia.com/records/fda_inspections/michael-l-levin-md/676c56e8-8bef-4e39-aa36-b4442656d354)
- [FDA Inspection 1133566 - 2020-11-25](https://www.keypedia.com/records/fda_inspections/michael-l-levin-md/733767a5-6b65-44c8-ad8c-46336d0595ec)

Company: https://www.keypedia.com/companies/michael-l-levin-md/72582320-ffbd-43ff-a97f-5c176a3a4104

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d